Skip to main content
padlock icon - secure page this page is secure


Buy Article:

$17.00 + tax (Refund Policy)

ERYTHROMYCIN, A MACROLIDE ANTIBIOTIC, HAS BEEN USED widely in pediatrics to treat a number of infections. Initially given as an alternative to penicillin because of that drug's potential for allergic reactions, erythromycin was first introduced in 1952.1 Erythromycin is currently used in neonatal settings for treatment of infections caused by Chlamydia, Ureaplasma, and Mycoplasma.1,2 Prophylaxis for ophthalmia neonatorum and treatment of otitis media are often managed with erythromycin. Erythromycin is the only drug currently proven effective for both prophylaxis and treatment of Bordetella pertussis (not a common pathogen in neonatal intensive care units, however).

No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Document Type: Research Article

Publication date: September 1, 1999

More about this publication?
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more